SCHEMBL97468

SCHEMBL97468

[CH2]CNCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL146820 0.82
SCHEMBL144566 0.79 CYP2C19 (0.53)
SCHEMBL8773694 0.79 CYP2C19 (0.53)
Diethylamine SCHEMBL27752325 0.78
SCHEMBL10364489 0.77
SCHEMBL10364450 0.77 CYP2C19 (0.63)
Diethylamine SCHEMBL27897365 0.75
Diethylamine SCHEMBL8915993 0.73
Diethylamine SCHEMBL11785374 0.73
Diethylamine SCHEMBL27918805 0.73 TP53 (0.80)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6895 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4121802-B1 HIGH REFRACTIVE INDEX SILOXANE INSERT MATERIALS FOR EMBEDDED CONTACT LENSES ALCON INC (CH) 2024-07-17 EP claimed
EP-4384310-A1 DEGRADABLE DELIVERY PARTICLES BASED FROM AMINE CONTAINING NATURAL MATERIALS Encapsys, LLC (US) 2024-06-19 EP claimed
EP-4384311-A1 ARTICLES OF MANUFACTURE WITH DEGRADABLE DELIVERY PARTICLES BASED FROM AMINE CONTAINING NATURAL MATERIALS Encapsys, LLC (US) 2024-06-19 EP claimed
EP-4076916-B1 WETTABLE SILICONE HYDROGEL CONTACT LENSES ALCON INC (CH) 2024-06-12 EP claimed
WO-2024114793-A1 SALT FORM AND CRYSTAL FORM OF UBIQUITINATION-SPECIFIC PROTEASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 杭州普济远成生物医药科技有限公司 2024-06-06 WO claimed
US-11999879-B2 Adhesive film and display member comprising the same SAMSUNG SDI CO., LTD. (KR) 2024-06-04 US claimed
US-11999908-B2 Method for making photochromic contact lenses ALCON INC. (CH) 2024-06-04 US claimed
CN-118121608-A Ubiquitin specific protease inhibitor salt form, ubiquitin specific protease inhibitor crystal form, preparation methods and application of ubiquitin specific protease inhibitor salt form and ubiquitin specific protease inhibitor crystal form 杭州普济远成生物医药科技有限公司 2024-06-04 CN claimed
EP-4369081-A2 METHOD FOR PRODUCING AN OPHTHALMIC PRODUCT Alcon Inc. (CH) 2024-05-15 EP claimed
US-20240147990-A1 Delivery Particles Based On Amine-Thiol-Ene Conjugates and Derivatives ENCAPSYS, LLC (US) 2024-05-09 US claimed
EP-0165226-B1 4-AMINO-BUTANOIC-ACID DERIVATIVES, PREPARATION AND USE SANOFI (FR) 1989-03-15 EP claimed
EP-0272694-A1 2-Dithioalkyl-dihydropyridines, a method for their preparation and pharmaceutical compositions containing them BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1988-06-29 EP claimed
EP-0201829-A1 1-Aryl-4-quinolone-3-carboxylic acids BAYER AG (DE) 1986-11-20 EP claimed
EP-0031708-B1 CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR ICI PHARMA (FR) 1984-06-13 EP claimed
EP-0075434-A2 Cephalosporins, their preparation and their pharmaceutical compositions ICI PHARMA (FR) 1983-03-30 EP claimed
EP-0071370-A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them ICI PHARMA (FR) 1983-02-09 EP claimed
EP-0052856-A2 Aryl sulfonylurea carbamates and thiolcarbamates and salts thereof: herbicidal antidotes STAUFFER CHEMICAL COMPANY (US) 1982-06-02 EP claimed
EP-0031708-A2 Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor ICI PHARMA (FR) 1981-07-08 EP claimed
US-4057539-A DYES, COLORFASTNESS MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1977-11-08 US claimed
US-3933800-A O-SUBSTITUTED OXIMES, MICROBIOCIDES GRUPPO LEPETIT S.P.A. (IT) 1976-01-20 US claimed